Where can I buy Capatinib?

Capmatinib (Capmatinib) is a drug that targets those carrying the MET gene14 Targeted therapeutic drugs for advanced or metastatic non-small cell lung cancer (NSCLC) with exon skipping mutations (METex14). However, Capmatinib (Capatinib) is not currently available in China, so patients cannot purchase the drug domestically and need to obtain it through overseas channels.

The price of foreign original drugs is relatively high, most of which are around tens of thousands of yuan. This can be a financial burden for many patients. However, there are also some foreign generic drugs, mainly Laos generic drugs, which are relatively cheap, about 3,000 yuan. The ingredients of these generic drugs are basically the same as those of the original drugs, so they can meet the treatment needs of patients to a certain extent.

One of the main ways to purchaseCapatinib is through an international medical organization or drug supplier. Patients can contact foreign drug suppliers or medical institutions to purchase drugs that meet regulations. However, when purchasing medications, patients need to ensure that they are obtained through legal channels and comply with local pharmaceutical standards and regulations.

In addition, some patients may choose to participate in clinical trials or drug clinical trial programs for the opportunity to obtain new or experimental drugs. By participating in clinical trials, patients have the opportunity to receive medicines for free and contribute to scientific research.

In summary, for Chinese patients, purchasing capmatinib may need to be obtained through overseas channels. Although brand-name drugs are more expensive, relatively cheaper generic drugs are also available. Patients should pay attention to ensure the legality and safety of the drugs when purchasing drugs, and follow the doctor's recommendations and prescriptions to ensure safe and effective treatment.